Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (211-220 of 566) with videos related to

Pageof 57
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2012
Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsiesSamih H Nasr, Anthony M Valeri, Sanjeev Sethi, et al.
Blood|May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsGiada Bianchi, Robert A Kyle, Colin L Colby, et al.
American Journal of Nephrology|April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantationHarris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportDavid L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood|September 19, 2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposureMichael Wang, Meletios A Dimopoulos, Christine Chen, et al.
Blood|June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of boneDavid Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myelomaS Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood|November 2, 2011
Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUSAlvin C Ng, Sundeep Khosla, Natthinee Charatcharoenwitthaya, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Pageof 57

Showing results (211-220 of 566) with videos related to

Sort By:
Pageof 57
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2012
Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsiesSamih H Nasr, Anthony M Valeri, Sanjeev Sethi, et al.
Blood|May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsGiada Bianchi, Robert A Kyle, Colin L Colby, et al.
American Journal of Nephrology|April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantationHarris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportDavid L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood|September 19, 2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposureMichael Wang, Meletios A Dimopoulos, Christine Chen, et al.
Blood|June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of boneDavid Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myelomaS Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood|November 2, 2011
Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUSAlvin C Ng, Sundeep Khosla, Natthinee Charatcharoenwitthaya, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Pageof 57